🔎 Trials Near Me

Početna › Ulcerativni kolitis › Florida

Kliničke studije za Ulcerativni kolitis u državi Florida

31 studija za Ulcerativni kolitis traži sudionike na lokacijama u državi Florida.

Gradovi u državi Florida

Službeni tekst studije (engleski)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Synergy Healthcare - Bradenton - 17th Avenue West /ID# 284157, Bradenton
  • Clinical Research of Osceola /ID# 280593, Kissimmee
  • Florida Center For Gastroenterology - Largo /ID# 281059, Largo
  • i još 3
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Access Research Institute, Brooksville
  • Gastro Florida, Clearwater
  • Digestive and Liver Center of Florida, P.A., Kissimmee
  • i još 5
U tijeku regrutacijaFaza 4
Od 18 do 80 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

  • Nicklaus Children's Hospital - Miami - Southwest 62nd Avenue /ID# 271585, Miami
U tijeku regrutacijaFaza 3
Od 2 do 17 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07071519

Confirmatory Clinical Study in Active Ulcerative Colitis

  • ARA Professionals, Miami
  • Orlando Gastroenterology, P.A., Orlando
  • Tropical Clinical Trials, Palmetto Bay
U tijeku regrutacijaFaza 2
Od 16 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07296315

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Novum Research, LLC, Clermont
  • I.V.A.M. Clinical & Investigational Center, LLC, Doral
  • Florida Research Institute, Lakewood Rch
  • i još 9
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Bradenton
  • Xencor Investigative Site, Brandon
  • Xencor Investigative Site, Jacksonville
  • i još 5
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 007, Kissimmee
  • 029, Miami
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-026, Orlando
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

  • Nature Coast Clinical Research ( Site 1045), Inverness
  • Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072), Miami
  • AdventHealth Orlando ( Site 1074), Orlando
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT07463183

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  • Clinical Research of Osceola, LLC, Kissimmee
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • American Institute of Research, Cutler Bay
  • Nature Coast Clinical Research, Inverness
  • Florida Research Institute, Lakewood Rch
  • i još 1
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Research Associates of South Florida - Miami - Southwest 8th Street, Miami
  • Gastro Health Research - Miami, Miami
  • Orlando Health, Orlando
  • i još 3
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • NeoClinical Research, Hialeah
  • Encore Borland-Groover Clinical Research, Jacksonville
  • Clinical Research of Osceola, Kissimmee
  • i još 4
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • Gastro Health Research - Miami, Miami
  • Ezy Medical Research, Miami Lakes
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07483073

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • K2 Medical Research - Daytona Beach, Daytona Beach
  • Clinical Research of Osceola, Kissimmee
  • Florida Research Institute, Lakewood Rch
  • i još 1
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • Endoscopic Research Inc, Orlando
  • Alliance Clinical Research of Tampa, LLC, Tampa
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06095128

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

  • Miami Clinical Research, Miami
  • GCP Clinical Research, Tampa
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT07513181

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Royal Palm Clinical Research - Site Number: 8400065, Fort Myers
  • Clinical Research of Osceola - Site Number: 8400013, Kissimmee
  • Bioresearch Partner-Kendale Lakes - Site Number: 8400053, Miami
  • i još 1
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07185009

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis

  • Syneos Health Miami, Miami
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 55 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07749768

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • Florida Research Center Inc., Lakewood Rch
  • Sanchez Clinical Research, Inc, Miami
  • GCP Clinical Research, Tampa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT07577856

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

  • Primary Care of Osceola, Kissimmee
  • Florida Research Institute, Lakewood Rch
  • University of Miami, Miami
  • i još 1
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 21. kol 2026. · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Novum Research, LLC - Site Number: 8400003, Clermont
  • Precision Clinical Research-Site Number: 8400059, Coral Springs
  • Sarkis Clinical Trials-Ocala - Site Number: 8400048, Gainesville
  • i još 12
U tijeku regrutacijaFaza 3
Od 16 do 80 godina · Oba spola · Ažurirano 20. kol 2026. · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Mayo Clinic Jacksonville, Jacksonville
  • Advent Health, Orlando
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • University of Miami, Miami
  • AdventHealth, Orlando
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • Digestive and Liver Center of Florida Kissimmee, Kissimmee
  • Orlando Health/Digestive Health Institute, Orlando
U tijeku regrutacijaOpažajna studija
Od 18 do 64 godina · Oba spola · Ažurirano 9. srp 2026. · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • Arnold Palmer Hospital - Center for Digestive Health and Nutrition, Orlando
U tijeku regrutacijaFaza 2
Od 12 do 17 godina · Oba spola · Ažurirano 8. srp 2026. · NCT05287126

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

  • AP Medical Research LLC, Miami
  • Edward Jenner Research Group, LLC, Plantation
  • Adtremed Research Clinic, Tampa
U tijeku regrutacijaFaza 1
Od 18 do 65 godina · Oba spola · Ažurirano 12. lip 2026. · NCT05666960

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

  • Med-Care Research Corp, Miami
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 22 godina i više · Oba spola · Ažurirano 28. tra 2026. · NCT06810518

Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)

  • University of Miami Health System, Miami
U tijeku regrutacija
Od 16 do 75 godina · Oba spola · Ažurirano 30. ožu 2026. · NCT06784323

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Miami
  • Mirador Therapeutics Selected Site, Miami
  • Mirador Therapeutics Selected Site, Miami
  • i još 3
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 12. ožu 2026. · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • University of Miami Health, Miami
  • Orlando Health, Orlando
U tijeku regrutacija
Od 18 do 85 godina · Oba spola · Ažurirano 8. sij 2026. · NCT05987852

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.